Table 1 Clinical characteristics of the population with positive and negative CUS at admission. Data are reported as mean ± SD for continuous variables and % for categorical variables
Negative cus at admission | Positive cus at admission | P | |
|---|---|---|---|
N | 2042 | 58 | - |
Age (years) | 71 ± 16 | 77 ± 14 | 0.009 |
Age > 70 years, n (%) | 1181 (57.8%) | 43 (74.1%) | 0.013 |
Female, n (%) | 971 (47.8%) | 31 (53.4%) | 0.399 |
BMI (Kg/m2) | 27 ± 5 | 26 ± 4 | 0.083 |
Current Smoking, n (%) | 461 (22.6%) | 15 (25.9%) | 0.557 |
Diabetes, n (%) | 532 (26%) | 12 (20.7%) | 0.358 |
Hypertension, n (%) | 1275 (62.4%) | 34 (58.6%) | 0.554 |
Myocardial infarction or STROKE, n (%) | 298 (14.6%) | 4 (6.9%) | 0.099 |
Acute infection, n (%) | 652 (31.9%) | 25 (43.1%) | 0.073 |
Pneumonia, n (%) | 300 (14.7%) | 10 (17.2%) | 0.589 |
Active Cancer, n (%) | 306 (15%) | 15 (29%) | 0.003 |
Previous VTE, n (%) | 78 (3.8%) | 5 (8.6%) | 0.064 |
Reduced mobility, n (%) | 549 (26.9%) | 21 (36.2%) | 0.115 |
Thrombophilia, n (%) | 15 (0.7%) | 4 (6.9%) | < 0.0001 |
Kidney failure, n (%) | 399 (19.5%) | 9 (15.5%) | 0.445 |
Heart or respiratory failure, n (%) | 470 (23%) | 19 (32.8%) | 0.083 |
Dyslipidemia, n (%) | 682 (33.4%) | 14 (24%) | 0.140 |
D-dimer (µg/mL)a | 1,51 ± 1,47 | 3,25 ± 1,49 | < 0.0001 |
Albumin (g/L) | 40 ± 9 | 35 ± 5 | 0.245 |
Hormone therapy, n (%)b | 81 (4%) | 3 (5.2%) | 0.644 |
Antiplatelet therapy, n (%)c | 796 (39%) | 26 (44.8%) | 0.373 |